{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:02:34Z","timestamp":1785240154425,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T00:00:00Z","timestamp":1500940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17H04317"],"award-info":[{"award-number":["17H04317"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17K11026"],"award-info":[{"award-number":["17K11026"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16K20067"],"award-info":[{"award-number":["16K20067"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"publisher","award":["S1311002"],"award-info":[{"award-number":["S1311002"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"publisher","award":["17-A-1-01"],"award-info":[{"award-number":["17-A-1-01"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bone.2017.07.024","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T02:45:16Z","timestamp":1501037116000},"page":"241-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9304-2098","authenticated-orcid":false,"given":"Takenobu","family":"Katagiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-6651","authenticated-orcid":false,"given":"Sho","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5605-9197","authenticated-orcid":false,"given":"Mai","family":"Kuratani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.07.024_bb0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/206489a0","article-title":"Suggested sequential mode of control of changes in cell behavior in adult bone remodeling","volume":"206","author":"Hattner","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.bone.2017.07.024_bb0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00003086-199001000-00036","article-title":"Role of transforming growth factor-\u03b2 in bone remodeling","volume":"250","author":"Bonewald","year":"1990","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2017.07.024_bb0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.150.3698.893","article-title":"Bone: formation by autoinduction","volume":"150","author":"Urist","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.bone.2017.07.024_bb0020","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1177\/00220345710500060601","article-title":"Bone morphogenetic protein","volume":"50","author":"Urist","year":"1971","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2017.07.024_bb0025","doi-asserted-by":"crossref","first-page":"7599","DOI":"10.1073\/pnas.78.12.7599","article-title":"Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation","volume":"78","author":"Sampath","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.07.024_bb0030","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1073\/pnas.80.21.6591","article-title":"Homology of bone-inductive proteins from human, monkey, bovine, and rat extracellular matrix","volume":"80","author":"Sampath","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.07.024_bb0035","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1073\/pnas.82.8.2267","article-title":"Purification and characterization of two cartilage-inducing factors from bovine demineralized bone","volume":"82","author":"Seyedin","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.07.024_bb0040","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1073\/pnas.85.24.9484","article-title":"Purification and characterization of other distinct bone-inducing factors","volume":"85","author":"Wang","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.07.024_bb0045","doi-asserted-by":"crossref","first-page":"13377","DOI":"10.1016\/S0021-9258(18)80003-5","article-title":"Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation","volume":"264","author":"Luyten","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.07.024_bb0050","doi-asserted-by":"crossref","first-page":"13198","DOI":"10.1016\/S0021-9258(19)38285-7","article-title":"Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-\u03b2 superfamily","volume":"265","author":"Sampath","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.07.024_bb0055","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.3201241","article-title":"Novel regulators of bone formation: molecular clones and activities","volume":"242","author":"Wozney","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.bone.2017.07.024_bb0060","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1073\/pnas.87.24.9843","article-title":"Identification of transforming growth factor \u03b2 family members present in bone-inductive protein purified from bovine bone","volume":"87","author":"Celeste","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.07.024_bb0065","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1016\/S0021-9258(17)38436-3","article-title":"Cartilage-inducing factor-A: apparent identity to transforming growth factor-\u03b2","volume":"261","author":"Seyedin","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.07.024_bb0070","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/S0021-9258(18)61601-1","article-title":"Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-\u03b2","volume":"262","author":"Seyedin","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.07.024_bb0075","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1242\/jcs.00417","article-title":"Macroscopic cartilage formation with embryonic stem-cell-derived mesodermal progenitor cells","volume":"116","author":"Nakayama","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bone.2017.07.024_bb0080","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1073\/pnas.84.20.7109","article-title":"Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography","volume":"84","author":"Sampath","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.07.024_bb0085","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1210\/endo-124-6-2991","article-title":"In vivo stimulation of bone formation by transforming growth factor-\u03b2","volume":"124","author":"Noda","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2017.07.024_bb0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0934-8832(11)80234-9","article-title":"Transforming growth factor-beta 2 enhances the osteoinductive activity of a bovine bone-derived fraction containing bone morphogenetic protein-2 and 3","volume":"11","author":"Bentz","year":"1991","journal-title":"Matrix"},{"key":"10.1016\/j.bone.2017.07.024_bb0095","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1083\/jcb.127.6.1755","article-title":"Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage","volume":"127","author":"Katagiri","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2017.07.024_bb0100","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0092-8674(83)90300-8","article-title":"Cytoplasmic activation of human nuclear genes in stable heterocaryons","volume":"32","author":"Blau","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.07.024_bb0105","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/270725a0","article-title":"Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle","volume":"270","author":"Yaffe","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bone.2017.07.024_bb0110","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2106\/00004623-200308000-00017","article-title":"Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs)","volume":"85-A","author":"Cheng","year":"2003","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2017.07.024_bb0115","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1515\/hsz-2012-0310","article-title":"The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway","volume":"394","author":"Katagiri","year":"2013","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bone.2017.07.024_bb0120","doi-asserted-by":"crossref","first-page":"a021899","DOI":"10.1101\/cshperspect.a021899","article-title":"Bone morphogenetic proteins","volume":"8","author":"Katagiri","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bone.2017.07.024_bb0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molcel.2007.11.039","article-title":"Cooperative assembly of TGF-\u03b2 superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding","volume":"29","author":"Groppe","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bone.2017.07.024_bb0130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/370341a0","article-title":"Mechanism of activation of the TGF-\u03b2 receptor","volume":"370","author":"Wrana","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bone.2017.07.024_bb0135","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/j.1460-2075.1995.tb07214.x","article-title":"GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-\u03b2 receptor complex","volume":"14","author":"Wieser","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2017.07.024_bb0140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/excr.1997.3680","article-title":"Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts","volume":"235","author":"Akiyama","year":"1997","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bone.2017.07.024_bb0145","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1091\/mbc.10.11.3801","article-title":"Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation","volume":"10","author":"Fujii","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bone.2017.07.024_bb0150","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1073\/pnas.93.2.790","article-title":"Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor \u03b2 pathway components","volume":"93","author":"Savage","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.07.024_bb0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/genetics\/139.1.241","article-title":"Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila","volume":"139","author":"Raftery","year":"1995","journal-title":"Genetics"},{"key":"10.1016\/j.bone.2017.07.024_bb0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0092-8674(00)81335-5","article-title":"Nomenclature: vertebrate mediators of TGF\u03b2 family signals","volume":"87","author":"Derynck","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.07.024_bb0165","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2443.2002.00573.x","article-title":"Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis","volume":"7","author":"Katagiri","year":"2002","journal-title":"Genes Cells"},{"key":"10.1016\/j.bone.2017.07.024_bb0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00774-012-0381-1","article-title":"Identification of a novel bone morphogenetic protein (BMP)-inducible transcript, BMP-inducible transcript-1, by utilizing the conserved BMP-responsive elements in the Id genes","volume":"31","author":"Shin","year":"2013","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2017.07.024_bb0175","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1093\/nar\/gkr572","article-title":"ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif","volume":"39","author":"Morikawa","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bone.2017.07.024_bb0180","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/emboj\/17.11.3091","article-title":"Direct binding of Smad3 and Smad4 to critical TGF\u03b2-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene","volume":"17","author":"Dennler","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bone.2017.07.024_bb0185","doi-asserted-by":"crossref","first-page":"28107","DOI":"10.1074\/jbc.272.44.28107","article-title":"Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling","volume":"272","author":"Souchelnytskyi","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.07.024_bb0190","doi-asserted-by":"crossref","first-page":"15577","DOI":"10.1074\/jbc.M109.028019","article-title":"Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins","volume":"285","author":"Nojima","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.07.024_bb0195","doi-asserted-by":"crossref","first-page":"7596","DOI":"10.1038\/srep07596","article-title":"Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling","volume":"4","author":"Tsukamoto","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.bone.2017.07.024_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1349-0079(10)80006-4","article-title":"Heterotopic bone formation induced by bone morphogenetic protein signaling: fibrodysplasia ossificans progressive","volume":"52","author":"Katagiri","year":"2010","journal-title":"J. Oral Biosci."},{"key":"10.1016\/j.bone.2017.07.024_bb0205","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1242\/dmm.010280","article-title":"Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis","volume":"5","author":"Kaplan","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bone.2017.07.024_bb0210","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM199608223350804","article-title":"Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressive","volume":"335","author":"Shafritz","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.07.024_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02555995","article-title":"Fibrodysplasia ossificans progressiva: a clue from the fly?","volume":"47","author":"Kaplan","year":"1990","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2017.07.024_bb0220","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressive","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.07.024_bb0225","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bone.2010.10.164","article-title":"A novel ACVR1 mutation in the glycine\/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date","volume":"48","author":"Gregson","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.07.024_bb0230","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bone.2017.07.024_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005005","article-title":"Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients","volume":"4","author":"Petrie","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2017.07.024_bb0240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ejhg.2008.178","article-title":"Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements","volume":"17","author":"Bocciardi","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bone.2017.07.024_bb0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10067-009-1283-z","article-title":"Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressive","volume":"29","author":"Ratbi","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bone.2017.07.024_bb0250","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-0004.2009.01256.x","article-title":"Mutational screening of ACVR1 gene in Brazilian fibrodysplasia ossificans progressiva patients","volume":"77","author":"Carvalho","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bone.2017.07.024_bb0255","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ajmg.a.32151","article-title":"A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H)","volume":"146A","author":"Furuya","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2017.07.024_bb0260","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/ajmg.a.37205","article-title":"Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of twopatients","volume":"167A","author":"Kaplan","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2017.07.024_bb0265","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"St. Jude Children's Research Hospital\u2013Washington University Pediatric Cancer Genome Project. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.07.024_bb0270","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.07.024_bb0275","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.07.024_bb0280","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1210\/me.2014-1301","article-title":"Mutant activin-like kinase 2 in fibrodysplasia ossificans progressiva are activated via T203 by BMP type II receptors","volume":"29","author":"Fujimoto","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bone.2017.07.024_bb0285","doi-asserted-by":"crossref","first-page":"36990","DOI":"10.1074\/jbc.M112.365932","article-title":"Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressive","volume":"287","author":"Chaikuad","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.07.024_bb0290","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1161\/CIRCULATIONAHA.108.843714","article-title":"Dominant-negative ALK2 allele associates with congenital heart defects","volume":"119","author":"Smith","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2017.07.024_bb0295","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ejhg.2010.224","article-title":"ALK2 mutation in a patient with Down's syndrome and a congenital heart defect","volume":"19","author":"Joziasse","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bone.2017.07.024_bb0300","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1038\/sj.onc.1210533","article-title":"Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway","volume":"26","author":"Craft","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2017.07.024_bb0305","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1093\/hmg\/ddu255","article-title":"ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant","volume":"2","author":"Haupt","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2017.07.024_bb0310","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/nm.2252","article-title":"Conversion of vascular endothelial cells into multipotent stem-like cells","volume":"16","author":"Medici","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.07.024_bb0315","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/jbmr.1562","article-title":"Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification","volume":"27","author":"Wosczyna","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.07.024_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1090","article-title":"Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification","volume":"8","author":"Dey","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bone.2017.07.024_bb0325","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2106\/JBJS.H.01177","article-title":"Identification of progenitor cells that contribute to heterotopic skeletogenesis","volume":"91","author":"Lounev","year":"2009","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2017.07.024_bb0330","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ncb2014","article-title":"Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle","volume":"12","author":"Uezumi","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bone.2017.07.024_bb0335","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/ncb2015","article-title":"Muscle injury activates resident fibro\/adipogenic progenitors that facilitate myogenesis","volume":"12","author":"Joe","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bone.2017.07.024_bb0340","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/jbmr.370","article-title":"Circulating osteogenic cells: implications for injury, repair, and regeneration","volume":"26","author":"Pignolo","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.07.024_bb0345","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2106\/JBJS.N.01056","article-title":"Heterotopic ossification: basic-science principles and clinical correlates","volume":"97","author":"Ranganathan","year":"2015","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2017.07.024_bb0350","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tibs.2015.11.010","article-title":"A door opens for fibrodysplasia ossificans progressiva","volume":"41","author":"Katagiri","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bone.2017.07.024_bb0355","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm.1888","article-title":"BMP type I receptor inhibition reduces heterotopic ossification","volume":"14","author":"Yu","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.07.024_bb0360","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nchembio.2007.54","article-title":"Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism","volume":"4","author":"Yu","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bone.2017.07.024_bb0365","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/cb9002865","article-title":"In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors","volume":"5","author":"Hao","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bone.2017.07.024_bb0370","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/cb300655w","article-title":"Development of an ALK2-biased BMP type I receptor kinase inhibitor","volume":"8","author":"Mohedas","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bone.2017.07.024_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062721","article-title":"A new class of small molecule inhibitor of BMP signaling","volume":"8","author":"Sanvitale","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2017.07.024_bb0380","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.bmcl.2013.03.113","volume":"23","author":"Engers","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bone.2017.07.024_bb0385","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nm.2334","article-title":"Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-\u03b3 agonists","volume":"17","author":"Shimono","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.07.024_bb0390","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jbmr.2820","article-title":"Palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human ACVR1(R206H) fibrodysplasia ossificans progressiva (FOP) mutation","volume":"31","author":"Chakkalakal","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.07.024_bb0395","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.apsb.2011.12.011","article-title":"Fungal Pyrrolidine-containing metabolites inhibit alkaline phosphatase activity in bone morphogenetic protein-stimulated myoblastoma cells","volume":"2","author":"Fukuda","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bone.2017.07.024_bb0400","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ja.2012.70","article-title":"Trichocyalides A and B, new inhibitors of alkaline phosphatase activity in bone morphogenetic protein-stimulated myoblasts, produced by Trichoderma sp. FKI-5513","volume":"65","author":"Fukuda","year":"2012","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bone.2017.07.024_bb0405","first-page":"26","article-title":"Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice","volume":"31","author":"Yamamoto","year":"2013","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2017.07.024_bb0410","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/gt.2011.193","article-title":"Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva","volume":"19","author":"Takahashi","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.bone.2017.07.024_bb0415","article-title":"Antisense-oligonucleotide mediated exon skipping in activin-receptor-like kinase 2: inhibiting the receptor that is overactive in fibrodysplasia ossificans progressive","volume":"8","author":"Shi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2017.07.024_bb0420","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bone.2017.07.024_bb0425","doi-asserted-by":"crossref","first-page":"15438","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressive","volume":"112","author":"Hino","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217302594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217302594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T22:06:40Z","timestamp":1658700400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217302594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":85,"alternative-id":["S8756328217302594"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.07.024","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}